Dose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Cancer
Clinical trial NCT01872377 · TERMINATED
Trial details
- NCT number
- NCT01872377
- Sponsor
- Ottawa Hospital Research Institute
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-01
- Primary completion
- 2018-05-16
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.